In mouse models of osteolytic breast cancer, inhibition of TGFβ activity, TGFβ release from bone (using zoledronic acid), Nox4, or RyR1 calcium leak all restored muscle force production [42]. The gene discussed is TGFB1; the disease is breast carcinoma.